RUTH HWANG: Open Payments
NPI 1821332156 · FULLERTON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$843 in 27 payments from 9 companies in 2025. Trend: 2023 $1,331 · 2024 $1,543 · 2025 $843
Food & beverage: $843
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 9 | $316 |
| Novo Nordisk Inc | 7 | $297 |
| Sequel Med Tech, LLC | 3 | $69 |
| Lilly USA, LLC | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $33 |
| Abbott Laboratories | 2 | $28 |
| Mannkind Corporation | 1 | $20 |
| Tandem Diabetes Care, Inc. | 1 | $16 |
| Dexcom, Inc. | 1 | $16 |
Products named: Korlym, Ozempic, TWIIST, MOUNJARO, Kerendia, FREESTYLE LIBRE 3, AFREZZA, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across CA — which companies pay providers there.
